Homology Medicines, Inc.

• BEDFORD, MA

How do I update this listing?

Create Email Alert

Homology Medicines is based out of Bedford. Homology Medicines, Inc. operates as a genetic medicines company. The Company offers a platform to utilize human hematopoietic stem cell derived adeno-associated virus vectors to treat a range of disease-causing mutations through gene correction, insertion, and knockout. Homology Medicines serves patients in the United States. The firm last filed a Form D notice of exempt offering of securities on 2017-08-10. The notice included securities offered of Equity

Contact Info

homology medicines, inc.
ONE PATRIOTS PARK
BEDFORD MA 01730
Business Phone: 781-301-7277

SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Recent SEC Filings

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Form D Filings

Form D is a form used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date	Form Type	Industry Group	Securities Offered	Total Offering Amount	Total Amount Sold
2017-08-10	D	PHARMACEUTICALS	Equity	83,500,008	83,500,008
2017-02-16	D/A	PHARMACEUTICALS	Equity	43,568,874	43,568,874
2016-01-06	D	PHARMACEUTICALS	Equity	23,068,876	23,068,876

Other Issuers in Filings
Name	Address
No Other Issuers

Related Parties included in filings
Name	Address	Relationship
KUSH PARMAR	subscription required	EXECUTIVE OFFICER DIRECTOR
PAUL STONE	subscription required	EXECUTIVE OFFICER DIRECTOR
RICHARD GREGORY	subscription required	DIRECTOR
ARTHUR TZIANABOS	subscription required	EXECUTIVE OFFICER DIRECTOR
STEVEN GILLIS	subscription required	DIRECTOR
SIYAMAK RASTY	subscription required	EXECUTIVE OFFICER
ALBERT SEYMOUR	subscription required	EXECUTIVE OFFICER
MAHENDRA SHAH	subscription required	DIRECTOR
CAMERON WHEELER	subscription required	DIRECTOR
BRAD SMITH	subscription required	EXECUTIVE OFFICER